Financial reports
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
30 Mar 22
10-Q
2021 Q3
Quarterly report
12 Nov 21
10-Q
2021 Q2
Quarterly report
13 Aug 21
10-Q
2021 Q1
Quarterly report
24 May 21
10-K/A
2020 FY
Annual report (amended)
19 May 21
Current reports
8-K
Other Events
18 Nov 22
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
22 Dec 21
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
13 May 21
8-K
Population Health Investment Co., Inc. Announces the Forward Looking Statements
5 Jan 21
8-K
Report of Independent Registered Public Accounting Firm
27 Nov 20
8-K
Population Health Announces Pricing Of $150 Million Initial Public Offering
20 Nov 20
Registration and prospectus
15-12G
Securities registration termination
12 Dec 22
25-NSE
Exchange delisting
29 Nov 22
424B4
Prospectus supplement with pricing info
19 Nov 20
8-A12B
Registration of securities on exchange
16 Nov 20
S-1/A
IPO registration (amended)
12 Nov 20
S-1
IPO registration
30 Oct 20
DRS
Draft registration statement
24 Sep 20
Proxies
No filings
Ownership
SC 13G/A
MAVERICK CAPITAL LTD
14 Feb 23
SC 13G/A
MILLENNIUM MANAGEMENT LLC
30 Jan 23
SC 13G
MILLENNIUM MANAGEMENT LLC
22 Apr 22
SC 13G
LEVIN CAPITAL STRATEGIES, L.P.
14 Feb 22
SC 13G/A
GLAZER CAPITAL, LLC
14 Feb 22
SC 13G/A
MAVERICK CAPITAL LTD
14 Feb 22
SC 13G/A
Foresite Capital Fund V, L.P.
11 Feb 22
SC 13G
Sculptor Capital LP
2 Feb 22
4
CLIVE MEANWELL
25 Aug 21
SC 13G
MAVERICK CAPITAL LTD
16 Feb 21